A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories

Bastian Fischer, Christoph Lichtenberg, Lisa Müller, Jörg Timm, Johannes Fischer, Cornelius Knabbe
doi: https://doi.org/10.1101/2021.03.15.21253588

Article Information

doi 
https://doi.org/10.1101/2021.03.15.21253588
History 
  • March 19, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Bastian Fischer1,
  2. Christoph Lichtenberg1,
  3. Lisa Müller2,
  4. Jörg Timm2,
  5. Johannes Fischer3,* and
  6. Cornelius Knabbe1
  1. 1Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Centre NRW, Bad Oeynhausen, Ruhr University Bochum, Bochum, Germany
  2. 2Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
  3. 3Institute for Transplantation Diagnostics and Cellular Therapeutics, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
  1. ↵*Corresponding author; email: bfischer{at}hdz-nrw.de
Back to top
Posted March 19, 2021.
Download PDF
Data/Code
Email
A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories
Bastian Fischer, Christoph Lichtenberg, Lisa Müller, Jörg Timm, Johannes Fischer, Cornelius Knabbe
medRxiv 2021.03.15.21253588; doi: https://doi.org/10.1101/2021.03.15.21253588
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area